Job Description
Job DescriptionFor Current Gilead Employees and Contractors:Please log onto your to apply for this job.At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.Job Description Patient Access to Care Director, UK&IThe positionThe Patient Access to Care (PAC) Director role is a commercial leadership position within the Liver & Acute Anti-infectives (AAI) BU and is responsible for leading Gilead’s non-promotional patient finding ‘Elimination Initiatives’ across UK and Ireland. Reporting to the Senior Business Unit Director, Liver & AAI, you’ll be responsible for Gilead’s cross-functional HCV patient finding strategy as well as accountable for elimination initiatives within Addiction services.In England, Gilead has established partnerships with the majority of providers of Addiction services providing funding to enable the deployment of HCV coordinators and data analysts across these settings. Working with NHS England’s Operational Delivery Networks (ODNs) our collective aim is to ensure that every individual in these settings is tested and treated via a patient pathway that works for them.In Wales, Ireland and Scotland, we are working with the National Programs to align and leverage Gilead’s patient finding expertise to complement the national initiatives and to identify areas of unmet need.You’ll be leading a high-performing, experienced team of field-based PAC managers that has won numerous HSJ awards, delivered micro-elimination in 52 sites and treated > 10,000 individuals.You’ll thrive in this role if you:enjoy leading through ambiguity and change managementare a dynamic, strategic thinker with a focus on measurable impactbring the right people together, set a collective ambition and work with a range of different stakeholders to achieve ithave the highest integrity and judgement of riskyou are driven by the mission and can inspire others to actThis role is a unique opportunity in your career; to contribute daily towards England being the first major country in the world to eliminate this virus; to work with the NHS and charities to drive change from within the system; and to evolve our patient finding beyond HCV into other disease areas within the BU.Specific Responsibilities:Develop and execute cross-functional Patient-finding strategy across UK&I to achieve target of number of patients commencing DAA treatmentManage Provider initiatives to achieve expected outcomes, deploying budget to unlock additional impact or expedite progress, whilst ensuring initiatives have patient care at their heartEnsure Gilead demonstrably acts as a true partner with NHSE and the ODNs, and meet tender obligationsLead, develop and equip PAC team, ensuring effective measurement and supporting tools/materialsInspire external stakeholders to act in pursuit of elimination as well keeping internal momentum locally and GloballyEnsure clear focus on compliance with industry regulations, legal requirements and internal business conduct policies in this sensitive and potentially complex area.As a member of the BU leadership team, actively contribute to the effective operation of the wider business unit, leading and supporting key initiativesKnowledge, Experience and Skills:Experience of patient pathway optimisation from diagnosis to treatment is an advantage, particularly in HCVProven success leading and developing a team within a performance-driven environmentDemonstrated ability to develop strategy and measure impact in a complex environment, execute with excellence and course correct as requiredExcellent cross-functional leadership – include and mobilise others to maximize their contribution to deliver the strategyExcellent internal and external stakeholder management – create productive relationships with a wide range of stakeholders being viewed as a valued partner.Strong understanding of industry code of conduct and key relevant legislation.Articulate and compelling communicatorExperience in external partnering and commercial relationships highly valuedDemonstrated ability to ruthlessly prioritise and deliver with impactAdditional backgroundMost recent estimates (2022) suggest that around 62,600 people in England are living with chronic Hepatitis C infection (HCV). HCV is a curable infection, and the UK Government has committed to eliminating the disease ahead of the WHO ambition of 2030. In the UK, injecting drug use continues to be the single largest risk factor for HCV infection, so testing is increasingly being undertaken in settings where those individuals are likely to be, such as in Addiction services, community pharmacies, homeless shelters, prisons and other healthcare settings.To support HCV Elimination, NHSE have worked with Pharmaceutical companies to establish an ‘Elimination framework’ whereby NHSE procures both medicines and Elimination initiatives.Gilead was awarded Gold status in that framework and since May 2019 has been working with partners to support HCV elimination. https://www.england.nhs.uk/2019/04/nhs-england-strikes-world-leading-deal-to-help-eliminate-hepatitis-c/Equal Employment Opportunity (EEO)It is the policy of Gilead Sciences, Inc. and its subsidiaries and affiliates (collectively "Gilead" or the "Company") to recruit select and employ the most qualified persons available for positions throughout the Company. Except if otherwise provided by applicable law, all employment actions relating to issues such as compensation, benefits, transfers, layoffs, returns from layoffs, company-sponsored training, education assistance, social and recreational programs are administered on a non-discriminatory basis (i.e. without regard to protected characteristics or prohibited grounds, which may include an individual’s gender, race, color, national origin, ancestry, religion, creed, physical or mental disability, marital status, sexual orientation, medical condition, veteran status, and age, unless such protection is prohibited by federal, state, municipal, provincial, local or other applicable laws). Gilead also prohibits discrimination based on any other characteristics protected by applicable laws.For Current Gilead Employees and Contractors:Please log onto your Internal Career Site to apply for this job.